IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 161 filers reported holding IMPAX LABORATORIES INC in Q3 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $383,000 | -79.6% | 18,888 | -83.8% | 0.03% | -79.9% |
| Q2 2017 | $1,874,000 | -44.8% | 116,390 | -56.6% | 0.14% | -40.1% |
| Q1 2017 | $3,395,000 | +63.8% | 268,377 | +71.6% | 0.23% | +78.5% |
| Q4 2016 | $2,073,000 | -80.8% | 156,429 | -65.6% | 0.13% | -82.3% |
| Q3 2016 | $10,808,000 | -26.3% | 454,597 | -9.5% | 0.73% | -12.1% |
| Q2 2016 | $14,669,000 | -9.1% | 502,073 | -0.4% | 0.84% | -9.1% |
| Q1 2016 | $16,135,000 | -26.1% | 503,896 | -1.3% | 0.92% | -4.6% |
| Q4 2015 | $21,835,000 | +38.1% | 510,635 | +13.7% | 0.96% | +15.6% |
| Q3 2015 | $15,814,000 | -37.2% | 449,142 | -18.1% | 0.83% | -19.9% |
| Q2 2015 | $25,197,000 | -7.2% | 548,711 | -5.3% | 1.04% | -2.9% |
| Q1 2015 | $27,155,000 | +20.9% | 579,361 | -18.3% | 1.07% | +13.6% |
| Q4 2014 | $22,463,000 | +4.3% | 709,045 | -22.0% | 0.94% | +4.8% |
| Q3 2014 | $21,543,000 | -9.6% | 908,595 | +14.3% | 0.90% | -2.6% |
| Q2 2014 | $23,831,000 | +61.3% | 794,641 | +42.1% | 0.92% | +64.4% |
| Q1 2014 | $14,775,000 | +26.1% | 559,245 | +20.0% | 0.56% | +33.5% |
| Q4 2013 | $11,713,000 | – | 465,915 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |